4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000106
EVP Commercial sold 1,137 shares at $1,047.11 ($1,190,564)
- EVP Commercial acquired 1,137 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
McCourt Marion · EVP Commercial
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-07-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,137 | $372.46 | $423,487 | 14,068 | D |
| 2024-07-01 | Sale : show line 2 in the form 10b5-1 | −1,137 | $1,047.11 | $1,190,564 | 12,931 | D |
| Open-market sales · 1,137 sh · avg $1,047.11 · $1,190,564 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-07-01 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −1,137 | 1,137 | D |
Loading xslF345X05/edgardoc.xml…